Essential Hypertension
Showing NaN - NaN of 7
Essential Hypertension Trial in Worldwide (Olmesartan medoxomil 40 mg - Amlodipine 10 mg, Olmesartan 40mg-Amlodipine
Completed
- Essential Hypertension
- Olmesartan medoxomil 40 mg - Amlodipine 10 mg
- +4 more
-
Graz, Austria
- +116 more
Dec 20, 2018
Essential Hypertension Trial in Worldwide (olmesartan medoxomil + amlodipine + hydroclororthiazide + , Olmesartan medoxomil +
Completed
- Essential Hypertension
- olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo
- +3 more
-
Antwerp, Belgium
- +132 more
Dec 20, 2018
Essential Hypertension Trial in Worldwide (olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets, olmesartan medoxomil
Completed
- Essential Hypertension
- olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets
- olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mg
-
Brugge, Belgium
- +40 more
Dec 20, 2018
Essential Hypertension Trial in Germany (olmesartan medoxomil, amlodipine)
Completed
- Essential Hypertension
- olmesartan medoxomil
- amlodipine
-
Hamburg, Germany
- +5 more
Dec 20, 2018
Essential Hypertension Trial in Germany, Russian Federation, United Kingdom (Eprosartan, Eprosartan Mesylate, Placebo Eprosartan
Essential Hypertension Trial in Worldwide (Azilsartan medoxomil/, Azilsartan medoxomil - chlorthalidone)
Completed
- Essential Hypertension
- Azilsartan medoxomil/placebo
- Azilsartan medoxomil - chlorthalidone
-
Haskovo, Bulgaria
- +107 more
Mar 21, 2014
Essential Hypertension Trial in Worldwide (olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary)
Completed
- Essential Hypertension
- olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary
-
Fulpmes, Austria
- +78 more
Nov 23, 2010